Targeting antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity.
Ordikhani F, Uehara M, Kasinath V, Dai L, Eskandari SK, Bahmani B, Yonar M, Azzi JR, Haik Y, Sage PT, Murphy GF, Annabi N, Schatton T, Guleria I, Abdi R.
Ordikhani F, et al. Among authors: azzi jr.
JCI Insight. 2018 Oct 18;3(20):e122700. doi: 10.1172/jci.insight.122700.
JCI Insight. 2018.
PMID: 30333312
Free PMC article.